1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, June 2016 (p10)

Drug Discovery and Development Analysis & Statistics, June 2016 (p10)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

271-300 of about 2 500 reports

Purchase Reports From Reputable Market Research Publishers

Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016

Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Caspase 9 (Apoptotic Protease Mch-6 or Apoptotic Protease-Activating Factor 3 or ICE-Like Apoptotic Protease 6 or EC 3.4.22.62) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Caspase ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, ...

  • Industries : Cancer, Biopharmaceutical, Drug Discovery and Development, Therapy, Pharmaceutical, Pathology
  • Countries : United States, World, United Kingdom
Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Aurora Kinase A (Serine ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States, China, World
Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase Chk1 ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : World, United States
Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016’, provides in depth analysis on Toll ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 ...

  • Industries : Mental Health, Pharmaceutical, Pathology, Therapy
  • Countries : United States
Intercellular Adhesion Molecule 1 (ICAM-1 or Major Group Rhinovirus Receptor or CD54) - Pipeline Review, H1 2016

Intercellular Adhesion Molecule 1 (ICAM-1 or Major Group Rhinovirus Receptor or CD54) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Intercellular Adhesion Molecule 1 (ICAM-1 or Major Group Rhinovirus Receptor or CD54) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Intercellular Adhesion Molecule 1 (ICAM-1 or Majo ...

  • Industries : Pathology, Pharmaceutical, Therapy, Drug Discovery and Development
  • Countries : World, China, United States
Covance, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Covance, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
BioClinica, Inc. (formerly Bio-Imaging Technologies, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioClinica, Inc. (formerly Bio-Imaging Technologies, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : United States
BioFocus DPI Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioFocus DPI Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : General Medicine and Specialty Medicine, Pharmaceutical
  • Countries : United States, United Kingdom
Asterand plc (formerly Pharmagene plc) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Asterand plc (formerly Pharmagene plc) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Drug Discovery and Development
  • Countries : United States
ICON Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ICON Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States
Intersect ENT Inc. (XENT) - Product Pipeline Analysis, 2016 Update

Intersect ENT Inc. (XENT) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Intersect ENT Inc. (Intersect), formerly Sinexus, Inc. is a medical equipment company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. ...

  • Industries : General Medicine and Specialty Medicine, Drug Discovery and Development
  • Countries : United States
Milestone Scientific Inc. (MLSS) - Product Pipeline Analysis, 2016 Update

Milestone Scientific Inc. (MLSS) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Milestone Scientific Inc. (Milestone Scientific) is a medical device company that manufactures, designs, and distributes computer controlled drug delivery instruments. The company operates through ...

  • Industries : Drug Delivery, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
  • Countries : United States
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2016 Update

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Anika Therapeutics, Inc. (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions ...

  • Industries : Therapy
  • Countries : United States
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical ...

  • Industries : Cancer, Pathology
  • Countries : World
Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016" ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Penile Cancer Global Clinical Trials Review, H1, 2016

Penile Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Penile Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Penile Cancer clinical ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Therapy
  • Countries : World
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Malignant Mesothelioma Global Clinical Trials Review, H1, 2016

Malignant Mesothelioma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Malignant Mesothelioma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2016" provides an overview of Malignant ...

  • Industries : Drug Discovery and Development, Cancer, Pharmaceutical, Pathology
  • Countries : World
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : United States, World
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : United States, World
B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Small-Cell ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World
Neuroblastoma Global Clinical Trials Review, H1, 2016

Neuroblastoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Neuroblastoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroblastoma clinical ...

  • Industries : Cancer, Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Cancer, Pharmaceutical, Therapy, Drug Discovery and Development, Pathology
  • Countries : World
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016

Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Cancer, Drug Discovery and Development, Therapy, Pharmaceutical, Pathology
  • Countries : World
T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016

T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘T-Cell Surface Glycoprotein CD3 Epsilon ...

  • Industries : Biopharmaceutical, Biological Therapy, Biotechnology, Pathology, Chronic Disease
  • Countries : United States, World
Parkinson%s Disease - Pipeline Review, H1 2016

Parkinson%s Disease - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Parkinson's Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape. ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.